Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection
While combination therapy of Rituximab (RTX) and intravenous immunoglobulin (IVIg) (RIT) has been proposed as therapeutic strategy for the treatment of chronic active antibody-mediated rejection (CAMR), its efficacy has not been established. In this study, we compared clinical outcome between the tr...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Society of Nephrology
2014-06-01
|
| Series: | Kidney Research and Clinical Practice |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211913214000503 |